MENU
RCUS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Arcus Biosciences (RCUS) Ownership - Who owns Arcus Biosciences?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
3928 Point Eden Way
Phone
+1 510 694-6200
Employees
577
Web
https://www.arcusbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.47B
P/E Ratio
N/A
Total Cash
1.09B
Projected Growth
N/A
Total Debt
58M
Revenue
263M
Risk (Beta)
0.83
Dividend Yield
N/A
Total Cash/Share
11.90
Total Debt/Equity
N/A
Revenue/Share
3.06 USD as % of share price
Fundamentals
RCUS
Capitalization
1.47B
P/E Ratio
N/A
Risk (Beta)
0.83
Dividend Yield
N/A
Total Cash
1.09B
Total Cash/Share
11.90
Total Debt
58M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.06%
Revenue
263M
ROE
N/A
Book Value
565M
P/B Ratio
2.46
Cash Flow
N/A
Earnings
-3.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.6B
Current Ratio
5.24
Current Revenue Per Employee
83188.91
Dividends Per Share - Security
N/A
EBITDA
-257M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-22.10
Shares Held By Institutions
2.07B
Shares Outstanding - Current
91.5M
Total Liabilities
687M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-15.812
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which offers pre-clinical drug discovery and development solutions
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3928 Point Eden Way
Phone
+1 510 694-6200
Employees
577
Web
https://www.arcusbio.com